SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Blue Jet Healthcare - Quaterly Results

14 May 2025 Evaluate
The topline for the March 2025 quarter moved up 85.08% to Rs. 3404.45 millions as compared to Rs. 1839.45 millions during the year-ago period.The Net Profit of the company reported a remarkable increase of 177.64% to Rs. 1100.95  millions  from Rs. 396.54 millions in previous same quarter.Operating profit surged to 1521.93 millions from the corresponding previous quarter of 618.99 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 3404.45 1839.45 85.08 10299.85 7115.98 44.74 10299.85 7115.98 44.74
Other Income 122.25 88.32 38.42 462.56 288.60 60.28 462.56 288.60 60.28
PBIDT 1521.93 618.99 145.87 4239.86 2580.90 64.28 4239.86 2580.90 64.28
Interest 0.34 0.32 6.25 0.98 1.61 -39.13 0.98 1.61 -39.13
PBDT 1521.59 618.67 145.95 4238.88 2481.86 70.79 4238.88 2481.86 70.79
Depreciation 49.47 77.17 -35.89 177.89 280.91 -36.67 177.89 280.91 -36.67
PBT 1472.12 541.50 171.86 4060.99 2200.95 84.51 4060.99 2200.95 84.51
TAX 371.17 144.96 156.05 1008.96 563.44 79.07 1008.96 563.44 79.07
Deferred Tax 3.42 27.46 -87.55 41.21 21.44 92.21 41.21 21.44 92.21
PAT 1100.95 396.54 177.64 3052.03 1637.51 86.38 3052.03 1637.51 86.38
Equity 346.93 346.93 0.00 346.93 346.93 0.00 346.93 346.93 0.00
PBIDTM(%) 44.70 33.65 32.85 41.16 36.27 13.50 41.16 36.27 13.50

Blue Jet Healthcare Share Price

402.60 -4.70 (-1.15%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×